SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

Detalles Bibliográficos
Autores principales: Alexandra, Van Uytvanck, Sebastian, Wittnebel, Nathalie, Meuleman, Angela, Loizidou, Jean‐Corentin, Salengros, Chloé, Spilleboudt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287311/
https://www.ncbi.nlm.nih.gov/pubmed/34295477
http://dx.doi.org/10.1002/ccr3.4439
_version_ 1783723889769054208
author Alexandra, Van Uytvanck
Sebastian, Wittnebel
Nathalie, Meuleman
Angela, Loizidou
Jean‐Corentin, Salengros
Chloé, Spilleboudt
author_facet Alexandra, Van Uytvanck
Sebastian, Wittnebel
Nathalie, Meuleman
Angela, Loizidou
Jean‐Corentin, Salengros
Chloé, Spilleboudt
author_sort Alexandra, Van Uytvanck
collection PubMed
description Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.
format Online
Article
Text
id pubmed-8287311
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82873112021-07-21 SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report Alexandra, Van Uytvanck Sebastian, Wittnebel Nathalie, Meuleman Angela, Loizidou Jean‐Corentin, Salengros Chloé, Spilleboudt Clin Case Rep Case Reports Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution. John Wiley and Sons Inc. 2021-07-19 /pmc/articles/PMC8287311/ /pubmed/34295477 http://dx.doi.org/10.1002/ccr3.4439 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Alexandra, Van Uytvanck
Sebastian, Wittnebel
Nathalie, Meuleman
Angela, Loizidou
Jean‐Corentin, Salengros
Chloé, Spilleboudt
SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_full SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_fullStr SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_full_unstemmed SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_short SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_sort sars‐cov‐2 infection in hematological patients during allogenic stem cell transplantation: a double case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287311/
https://www.ncbi.nlm.nih.gov/pubmed/34295477
http://dx.doi.org/10.1002/ccr3.4439
work_keys_str_mv AT alexandravanuytvanck sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT sebastianwittnebel sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT nathaliemeuleman sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT angelaloizidou sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT jeancorentinsalengros sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT chloespilleboudt sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport

Ejemplares similares